학술논문

In vitro and in vivo Evaluation of the Efficacy and Safety of Powder Hydroxypropylmethylcellulose as Nasal Mucosal Barrier
Document Type
Academic Journal
Source
Medical Devices: Evidence and Research. May 31, 2020, p107, 7 p.
Subject
United Kingdom
Language
English
ISSN
1179-1470
Abstract
Introduction: Insufflation of powder hydroxypropylmethylcellulose (pHPMC) in the nose has been proven an effective barrier in subjects with rhinitis in many clinical studies. We conducted additionally in vitro and in vivo experiments to address outstanding efficacy and safety issues. Methods: We used an experimental setup to demonstrate the inhibition of the diffusion of allergen extracts (house dust mite, Japanese cedar, Ragweed, Timothy grass) and pollutants (particulate matter 2.5 [micro]m, PM2.5). Safety of pHPMC when insufflated in the airways of rats was assessed in 24 animals which were sacrificed; tissue sections from lungs, brain and liver were made 1, 24 and 48 hrs after pHPMC inhalation and compared to those of control animals. Results: pHPMC acted as an effective barrier to diffusion of both the liquid allergen extracts and of PM2.5 into the agar covered slides: the quantities of the other tested allergens ranged between Conclusion: Use of pHPMC should be viewed as a barrier enforcing measure against inhalatory ambient intruders. Keywords: cellulose, hydroxypropylmethylcellulose, HPMC, micronized powder, inhaled allergens, allergen barrier, particulate matter 2.5, PM2.5, safety in rats
Introduction Hay fever symptoms are triggered when the nasal mucosa is exposed to allergenic pollen and spores. Previously, numerous products, such as ointments and sprays, have been developed to act [...]